Online Program Home
My Program

CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

110 * ! Mon, 7/30/2018, 8:30 AM - 10:20 AM CC-West 215/216
Assessing Treatment Effects for Life History Processes — Topic Contributed Papers
Biopharmaceutical Section, Mental Health Statistics Section, ENAR
Organizer(s): Mouna Akacha , Novartis Pharma AG
Chair(s): Mouna Akacha , Novartis Pharma AG
8:35 AM Symptom Trials Vs Morbidity/Mortality Trials: Are Different Estimands Required?

Steven Snapinn, Amgen, Inc.
8:55 AM Recurrent Event Estimands: With or Without Competing Terminal Event

Jiawei Wei, Novartis
9:15 AM Assessment of a Treatment Effect for Recurrent Event Data in the Presence of a Terminal Event

Philip Hougaard, Lundbeck
9:35 AM Comparison of Event Rates Between On- and Off-Drug Treatment Periods for a Recurrent Adverse Event

Brenda Crowe, Eli Lilly & Co.; Haoda Fu, Eli Lilly and Company; Yebin Tao, Eli Lilly and Company
9:55 AM Discussant: Hsien-Ming James Hung, PhD, Food and Drug Administration
10:15 AM Floor Discussion